Nico Ullrich

Medicine · Health Sciences

5h-index594citations25works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(20), Chemical Synthesis and Analysis(17), Cell Adhesion Molecules Research(7), Synthesis and Biological Evaluation(7), Monoclonal and Polyclonal Antibodies Research(5)

Publications25 total

Supplementary Table 2 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Figure 2 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Information from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Table legend from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Figure 2 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Data from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Information from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Figure 1 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Table 1 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Figure 1 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Table 1 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Information from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Data from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Information from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Table 2 from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
Supplementary Table legend from CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
2023Open Access
CEACAM1: a novel target of MITF in malignant melanoma
Experimental Dermatology·2016
CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
Frontiers in Oncology·2015· 7 citedOpen Access
<scp>MITF</scp> is a critical regulator of the carcinoembryonic antigen‐related cell adhesion molecule 1 (<scp>CEACAM</scp>1) in malignant melanoma
Pigment Cell & Melanoma Research·2015· 11 cited
Evaluierung der klinischen und biologischen Relevanz von CEACAM1 Spleißvarianten im malignen Melanom
DuEPublico (University of Duisburg-Essen)·2015Open Access
page 1 of 2Next →

Frequent Co-authors

Dirk Schadendorf(21), Iris Helfrich(21), Bernhard B. Singer(19), Anja Heinemann(17), Elena Nilewski(17), Inka Scheffrahn(17), Joachim Klode(17), André Scherag(17), Till Milde(4), Andrey Korshunov(4), Stefan M. Pfister(4), Olaf Witt(4), Hendrik Witt(3), Thomas Hielscher(3), Hedwig E. Deubzer(3), I. Oehme(3), Marco Lodrini(3), Axel Benner(3), Andreas von Deimling(3), Andreas E. Kulozik(3)